Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A. Founded in 1976, Sofinnova has a long legacy of building what we believe are great companies in both the U.S. and Europe with approximately $3.7B in assets under management and committed capital as of 12/31/2023. 

Spark Therapeutics

Vera Therapeutics

Bolt Biotherapeutics

Coherus Biosciences

IVERIC bio

Enovix

Humanigen

Marinus Pharmaceuticals

Natera

Prothena

Aerovate Therapeutics

Akouos

Apellis Pharmaceuticals

Seagen

Seres Therapeutics

Athira Pharma

Gyroscope Therapeutics

immatics biotechnologies

Infovista

Invitae

Sofinnova Investments 

Google Maps

Microsoft Exchange Online

DMARC

Office 365 Mail

Microsoft Azure DNS

Google Maps API

Hubspot Hosted

Google Maps for Work

Chief Financial Officer, Sofinnova Partners

Christophe Blanche

Board Member & Cofounder

Martin Rothman

Financial Director

Bernard Ross

Director of Finance

Thomas Paul

Finance and Administration

Ahmed Fourati

Operations

Chris Humphrey

Events and Community Manager

Pam Putz

Venture Partner

Andrew Weiss

Head of Operations and Project Office

Anne-Sophie Castaigne

Engineering

Caroline Patard

Antoine Papiernik

Neil Mehta

Lamia Idrissi

Dominique Verdier

Lukas Guenther

Lucia Faccio

Partner, Sofinnova Telethon Fund

Anne Osdoit

Partner

Jacques Theurillat

Partner, Crossover fund

Guillaume Baxter

Senior Associate

Denis Lucquin

Managing Partner

Biotalys is an AgTech company that employs its proprietary AGROBODY™ technology platform to develop crop protection products.

Abivax develops medicines that alter the body's natural immune system mechanisms.

Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.

LimFlow SA is a venture-backed medical device company.

ReCor Medical has developed a unique therapeutic non-focused ultrasound system

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Investors Active in Midwestern US

Seed Stage Investors with Investments in Northeastern US

Late Stage Venture Investors with Investments in New England

European Union (EU) Seed Stage Investors

Sofinnova Partners is a venture capital firm that invests in the life sciences sector, from seed to later-stage.

The firm manages over €2 billion of assets dedicated to life science investing and actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact its collective future. It invests in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations with a focus on Life Sciences (Biopharmaceuticals / Biotech, Medical Devices, Industrial Biotechnology). Sofinnova Partners proactively sources deals, takes a lead role, is most often the first institutional investor in Round A financings, and leads its portfolio companies until exit. They sit on the boards of their portfolio companies and play an active role from the formation phase alongside entrepreneurs.

It was headquartered in Paris, Ile-de-France in 1972.

Apollo

Private Equity Round - Sofinnova Partners

Sofinnova Digital Medicine I

Sofinnova Venture Partners XI Flagship Fund

Sofinnova Digital Medicine Venture Fund

Sofinnova Industrial Biotech II

Sofinnova Capital X

Sofinnova Crossover Fund

Sofinnova Capital IX

MD Start III

Sofinnova Telethon

Sofinnova Crossover I

Paris

Ile-de-France

France

Europe

Sofinnova Partners

European Agri-Tech Company Elicit Plant Secures $48M in Series B to Bankroll US Expansion

BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations

Cure51 launches NHS-approved study with Cambridge University Hospitals and seven other leading UK oncology institutions to unlock cancer survival secrets

Elicit Plant Announces $48 Million B Series Fundraising to accelerate global expansion and combat climate change

Elicit Plant Announces €45 Million Investment Round to Accelerate Global Expansion

Elicit Plant Raises $48M in Series B Funding

United States

North America

India

Asia

Bangladesh

United Kingdom

ARCH Venture Partners is a venture capital firm that focuses on the life sciences industry, providing funding and strategic support to biotech companies.

ARCH Venture Partners

OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector, with a focus on biopharmaceuticals, medical devices, and diagnostics.

OrbiMed

Canaan is an early-stage venture capital firm that invests in entrepreneurs with visionary ideas in biopharma, digital health, and medical technology.

Canaan

SR One is the corporate venture capital arm of GlaxoSmithKline, focusing on investing in emerging life science companies that are pursuing innovative solutions.

SR One

Flagship Pioneering is a unique life sciences innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies.

Flagship Pioneering

Atlas Ventures is a leading global venture capital firm that invests in technology and life sciences companies, supporting entrepreneurs in building successful businesses.

Atlas Ventures

TANOCAPITAL.COM is a competitor of Sofinnova Partners in the life sciences and sustainability investment space, providing capital and strategic support to similar companies.

TANOCAPITAL.COM

Fuller and Thaler Asset Management is a competitor of Sofinnova Partners, focusing on providing capital and strategic support to companies in the biotech, medtech, and green tech sectors.

Fuller and Thaler Asset Management

Light Street Capital is a competitor of Sofinnova Partners, specializing in providing capital and strategic support to start-ups, early-stage, and growth-stage companies in the biotech, medtech, and green tech sectors.

Light Street Capital

Quaker Partners is a competitor of Sofinnova Partners, providing capital and strategic support to companies in the life sciences and sustainability sectors.

Quaker Partners

Vector Asset Management, Inc. is a competitor of Sofinnova Partners, focusing on providing capital and strategic support to companies in the biotech, medtech, and green tech sectors.

Vector Asset Management, Inc.

Sanderling Ventures is a competitor of Sofinnova Partners, specializing in providing capital and strategic support to start-ups, early-stage, and growth-stage companies in the biotech, medtech, and green tech sectors.

Sanderling Ventures

SCP Vitalife Partners is a competitor of Sofinnova Partners, providing capital and strategic support to companies in the life sciences and sustainability sectors.

SCP Vitalife Partners

RoundTable Healthcare Partners is a competitor of Sofinnova Partners, focusing on providing capital and strategic support to companies in the biotech, medtech, and green tech sectors.

RoundTable Healthcare Partners

Truffle Capital is a competitor of Sofinnova Partners, specializing in providing capital and strategic support to start-ups, early-stage, and growth-stage companies in the biotech, medtech, and green tech sectors.

Truffle Capital

Mirova is a competitor of Sofinnova Partners, focusing on providing capital and strategic support to companies in the life sciences and sustainability sectors.

Mirova

Kyotherm is a competitor of Sofinnova Partners, specializing in providing capital and strategic support to start-ups, early-stage, and growth-stage companies in the biotech, medtech, and green tech sectors.

Kyotherm

Sofinnova Partners is a venture capital firm specializing in life sciences and sustainability investments. The company provides capital and strategic support to start-ups, early-stage, and growth-stage companies in the biotech, medtech, and green tech sectors. With a focus on innovation and sustainability, Sofinnova Partners aims to support companies that have the potential to make a significant impact on health and the environment.

news impact assignment basic	general
public peers	general	May 14, 2024 10:17 PM	c8fa9516
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	61826a64
crunchbase profile	general	Nov 22, 2024 8:43 AM	535d71a5
li profile	general	May 14, 2024 10:17 PM	eeb0d891
translate crunchbase fundingrounds	general	Nov 22, 2024 10:56 AM	c5e653fe
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:SOFINNOVA

Sofinnova Partners